Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

GSK

GSK (GSK)

GSK plc
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:GSK
DateTimeSourceHeadlineSymbolCompany
10/12/20199:44AMDow Jones NewsLONDON MARKETS: Brexit Hopes Sends British Pound To Highest Level Of Johnson Administration As U.K. Banks SoarNYSE:GSKGSK plc
10/11/20191:32PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NYSE:GSKGSK plc
10/11/201912:41PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NYSE:GSKGSK plc
10/11/201911:55AMDow Jones NewsLONDON MARKETS: Brexit Hopes Sends British Pound To Highest Level Of Johnson Administration As U.K. Banks SoarNYSE:GSKGSK plc
10/11/201910:34AMDow Jones NewsLONDON MARKETS: Brexit Hopes Sends British Pound To Highest Level Of Johnson Administration As U.K. Banks SoarNYSE:GSKGSK plc
10/11/20199:10AMDow Jones NewsLONDON MARKETS: Brexit Hopes Fuel Fresh Rally For The British Pound To Highest Level Of Johnson AdministrationNYSE:GSKGSK plc
10/11/20197:56AMDow Jones NewsLONDON MARKETS: Brexit Hopes Fuel Fresh Rally For The British Pound To Highest Level Of Johnson AdministrationNYSE:GSKGSK plc
10/11/20197:48AMDow Jones NewsLONDON MARKETS: Brexit Hopes Fuel Fresh Rally For The British PoundNYSE:GSKGSK plc
10/10/201912:30PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NYSE:GSKGSK plc
10/08/201911:26AMDow Jones NewsGlaxo Links Up with US Biotech to Target Solid Tumors with Cell TherapyNYSE:GSKGSK plc
10/02/20199:08AMBusiness WireGSK Submits Filing to FDA for Trelegy Ellipta Use in Patients With AsthmaNYSE:GSKGSK plc
10/01/20191:50PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NYSE:GSKGSK plc
10/01/201911:39AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NYSE:GSKGSK plc
09/30/201911:11AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NYSE:GSKGSK plc
09/30/20197:01AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NYSE:GSKGSK plc
09/30/20193:02AMDow Jones NewsGlaxoSmithKline Says Ovarian Cancer Study Validates Tesaro Acquisition -- WSJNYSE:GSKGSK plc
09/28/20193:59PMDow Jones NewsGlaxoSmithKline Says Ovarian Cancer Study Validates Tesaro AcquisitionNYSE:GSKGSK plc
09/28/201911:07AMDow Jones NewsGlaxoSmithKline Says Ovarian Cancer Study Validates Tesaro AcquisitionNYSE:GSKGSK plc
09/28/201910:31AMPR Newswire (US)Phase 3 PRIMA trial of Zejula® (niraparib) is the first study to show a PARP inhibitor significantly improves PFS, regardles...NYSE:GSKGSK plc
09/28/201910:31AMPR Newswire (Canada)Phase 3 PRIMA trial of Zejula® (niraparib) is the first study to show a PARP inhibitor significantly improves PFS, regardles...NYSE:GSKGSK plc
09/28/201910:31AMPR Newswire (US)Phase 3 PRIMA trial of Zejula® (niraparib) is the first study to show a PARP inhibitor significantly improves PFS, regardles...NYSE:GSKGSK plc
09/28/20192:53AMPR Newswire (US)GSK presents new data showing promising anti-tumour activity with GSK3359609, an ICOS receptor agonist, in combination with p...NYSE:GSKGSK plc
09/26/20191:48PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NYSE:GSKGSK plc
09/17/20191:26PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NYSE:GSKGSK plc
09/12/20194:42PMDow Jones NewsFDA Approves GlaxoSmithKline's Nucala For Children Ages 6-11 With Severe Eosinophilic AsthmaNYSE:GSKGSK plc
09/12/20193:48PMBusiness WireNucala is the first biologic approved in the US for six to 11-year-old children with severe eosinophilic asthmaNYSE:GSKGSK plc
09/11/201912:33PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NYSE:GSKGSK plc
09/05/20199:24AMDow Jones NewsPerrigo Buys Prevacid U.S. OTC Rights From GlaxoSmithKlineNYSE:GSKGSK plc
09/04/20191:56PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NYSE:GSKGSK plc
09/04/20199:51AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NYSE:GSKGSK plc
 Showing the most relevant articles for your search:NYSE:GSK